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Table. 30-day MACE by procedure
Primary outcome Women Men P value
All CEA 4.09% (110/2689) 4.05% (155/3829) .9492
All CAS 7.18% (108/1504) 6.88% (158/2297) .7453
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nosis of vEDS presenting at two tertiary referral centers
from 2000 to 2012 were reviewed. Data collected
included demographics, family history, vascular pathology,
operative details, and outcomes. To replicate the pheno-
type-genotype correlation a second cohort was reviewed
using data from the Genetically Triggered Thoracic Aortic
Aneurysms and Cardiovascular Conditions Registry (Gen-
TAC), a National Institutes of Health-funded multicenter
database.
Results: A total of 62 cases (34% male, 75% with
positive family history, 15% HI) were identiﬁed. Arterial
aneurysms and dissections were seen in 38 (62%) cases.
Median age at initial vascular presentation was 41 (range
39-58) years in the HI group vs 33 (range 17-68) years in
MIS group. Aortic and mesenteric arterial involvement
was more common in the HI than MIS group (44% vs
15% and 44% vs 23%, respectively). The mortality was
0% in the HI group and 17% in the MIS group. The Gen-
TAC registry enrolled 103 cases (29% male, 55% with
positive family history, 6% HI). Median age at diagnosis
was 28 (range 1-63) years. Once again, aortic involve-
ment was more common in the HI vs MIS group (50%
vs 10%).
Conclusions: Aortic and mesenteric arterial involve-
ment in vEDS appears to be related to the underlying
mutation type, with the HI cases having milder disease
and later presentation. Molecular diagnosis is warranted
in vEDS cases as it predicts postoperative outcomes and
guides surveillance.
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hub: Nothing to disclose.Symptomatic CEA 5.91% (57/964) 5.39% (81/1502) .5910
Symptomatic CAS 8.31% (56/674) 9.47% (101/1067) .4402
Asymptomatic CEA 3.07% (53/1725) 3.18% (74/2327) .9274
Asymptomatic CAS 6.27% (52/830) 4.63% (57/1230) .1092
All Symptomatic 6.90% (113/1638) 7.08% (182/2569) .8527
All Asymptomatic 4.11% (105/2555) 3.68% (131/3557) .4194S3: SVS Plenary Session III
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Objectives: While optimal treatment of carotid
stenosis remains unclear, available data suggest that women
have higher risk of adverse events after carotid revasculari-
zation. SVS-VR data was used to determine the impact of
gender after CEA and CAS.
Methods: 10,319 patients (41% women) underwent
CEA (6518) and CAS (3801). The primary end pointwas a composite of death, stroke and myocardial infarction
(MACE) at 30-days. The effect of symptom status and
gender on outcomes was also analyzed.
Results: There was no difference in age between
genders, but men were more likely to be symptomatic
(41% v 39%). Women were more likely to have hyperten-
sion and COPD while men had a higher prevalence of
CAD and smoking history. For disease etiology in CAS,
restenosis was more common in women (28% v 21%)
while radiation was higher in men (7% vs 3%). MACE
was lower for CEA in all patient groups in both genders
(P < .05 for all comparisons between CEA and CAS).
Comparing women and men (Table), there were no
statistically signiﬁcant differences in MACE for either
CEA (4% vs 4%) or CAS (7% vs 7%), which remained
even after stratiﬁcation by symptomatology and multivar-
iate risk adjustment.
Conclusions: In this large, real-world analysis, women
and men demonstrated similar results after CEA or CAS.
These data suggest that, contrary to previous reports,
women derive similar beneﬁts as men from carotid revascu-
larization. However, CAS is associated with inferior
outcomes compared to CEA for both women and men,
regardless of symptom status.
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Objectives: To determine the association between
progression of internal carotid artery stenosis and subse-
quent ipsilateral cerebral ischemic events (AF, TIA or
stroke) in the Asymptomatic Carotid Stenosis and Risk of
Stroke (ACSRS) Study.
Methods: 1121 patients with asymptomatic carotid
stenosis 50-99% in relation to the bulb diameter were
followed-up 6-monthly clinically and with carotid duplex
